We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Axicabtagene Ciloleucel (Axi-Cel) versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: ZUMA-7, A Phase 3, Randomized Study.
- Authors
Oluwole, Olalekan O.; Bishop, Michael R.; Gisselbrecht, Christian; Gordon, Leo I.; Kersten, Marie José; Maloney, David G.; Schmitz, Norbert; Caballero, Maria Dolores; Kuruvilla, John; Song, Kevin W.; Jacobson, Caron A.; Nastoupil, Loretta J.; Riedell, Peter; Jiang, Yizhou; Rossi, John M.; Lee, Lillian; Cheng, Paul; Locke, Frederick L.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2018, Vol 18, pS293
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2018.07.238